MARPLAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Marplan, and when can generic versions of Marplan launch?
Marplan is a drug marketed by Validus Pharms Inc and is included in one NDA.
The generic ingredient in MARPLAN is isocarboxazid. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the isocarboxazid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MARPLAN?
- What are the global sales for MARPLAN?
- What is Average Wholesale Price for MARPLAN?
Summary for MARPLAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 66 |
Patent Applications: | 4,192 |
Drug Prices: | Drug price information for MARPLAN |
What excipients (inactive ingredients) are in MARPLAN? | MARPLAN excipients list |
DailyMed Link: | MARPLAN at DailyMed |
Pharmacology for MARPLAN
Drug Class | Monoamine Oxidase Inhibitor |
Mechanism of Action | Monoamine Oxidase Inhibitors |
US Patents and Regulatory Information for MARPLAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Validus Pharms Inc | MARPLAN | isocarboxazid | TABLET;ORAL | 011961-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |